摘要
目的:探讨99Tcm-硫化铼胶体在乳腺癌前哨淋巴结(SLN)活检中的应用价值。方法:30例T1~T2期乳腺恶性肿瘤患者入选,术前15~24 h乳晕下注射99Tcm-硫化铼,使用SPECT/CT进行SLN淋巴显像,定位;术中用γ探测仪寻找SLN,行SLN活检后,常规行乳癌手术;术后对SLN活检和腋窝淋巴结(ALN)清扫的病理结果进行比较分析。结果:30例共有29例检到SLN,共检出SLN 31枚,检出率,准确率分别为97.67%,100%;SLN状态与腋淋巴结转移的符合率为100%,无假阳性及假阴性情况出现。结论:99Tcm-硫化铼用于乳腺癌SLN活检是一种较理想的核素示踪剂。
Objective: To investigate the clinical application value of 99^Tc^m-colloidal rhenium sulfide in sentinel lymph nodes (SLNs) biopsy in patients with breast cancer. Methods: Thirty patients with T1-T2 breast cancer were enrolled. Patients were injected with 99^Tc^m-colloidal rhenium sulfide under the areola 15-24 h before operation, and lymphoscintigraphy and mapping of the SLNs was subsequently performed with SPECT/CT. Gamma probe-guided SLNs detection and biopsy was employed during surgery before the breast cancer resection. The results of SLN biopsy and histological examination were compared and analyzed after surgery. Results: SLNs were detected in 29 of the 30 patients and a total of 31 SLNs were identified. The detection rate and accuracy rate was 97.67% and 100%, respectively. The coincidence rate of the SLNs status and axillary lymph node metastasis was 100%, and no false positive or negative detections occurred. Conclusion: 99^Tc^m-colloidal rhenium sulfide is an ideal tracer for SLNs biopsy in patients with breast cancer.
出处
《中国普通外科杂志》
CAS
CSCD
北大核心
2012年第11期1342-1345,共4页
China Journal of General Surgery